NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

NAMI is committed to ensuring accessibility for people with disabilities. If you would like to request an accessible version of any document on this page, please email us.

Filter By:
Regulatory Comment to HHS on Health Equity
11/13/2023
Regulatory comment to HHS on the proposed rule on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities, to clarify and strengthen the implementing regulation for Section 504 of the Rehabilitation Act of 1973.
Letter to Congressional Committee Leadership on Mental Health Workforce and Medicare
11/09/2023
Letter to Senate Finance Committee leadership expressing appreciation and support for the Better Mental Health Care, Lower Drug Cost and Extenders Act.
Letter to Congressional Leadership on Child and Adolescent Mental Health
11/08/2023
Letter of support to Senators Schumer and McConnell urging them to bring the Kids Online Safety Act to the Senate floor for a vote before the end of the year.
Letter to Congressional Leadership on Child and Adolescent Mental Health and Medicaid
11/07/2023
Letter urging Congressional Leadership to pass a permanent extension of CHIP through the Children’s Health Insurance Program Permanency (CHIPP) Act (H.R.4771).
Letter to Congressional Committee Leadership on Medicare and Mental Health Workforce
11/02/2023
Letter to Congressional Committees in support of the bipartisan Improving Access to Mental Health Act (S. 838/H.R. 1638), which will expand access to care by expanding the scope of clinical social workers (CSWs) in Medicare.
Letter to Congressional Committee Leadership on Mental Health Funding
10/30/2023
Letter to Senators Sanders and Cassidy requesting that the Senate HELP Committee brings forward the reauthorization of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act; P.L. 115-271) in regular order.
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health and Research and Treatment Innovation
10/19/2023
Letter asking Senate HELP Committee to include the Preventing Adverse Childhood Experiences (PACE) Act in its reauthorization of the SUPPORT for Patients and Communities Act.
Congressional Testimony on Child and Adolescent Mental Health
10/18/2023
NAMI CAO Hannah Wesolowski's congressional testimony, on behalf of NAMI, to the Democratic Women's Caucus on causes of and solutions to the mental health crisis among teen girls.
Regulatory Comment to HHS, EBSA and IRS on Parity
10/17/2023
Regulatory Comment to Secretary Becerra, Assistant Secretary Gomez, and Deputy Commissioner O'Donnell in support of the proposed rule on Requirements Related to the Mental Health Parity and Addiction Equity Act, and offering comments to strengthen the rule.
Regulatory Comment on Parity
10/16/2023
Regulatory comment to IRS, DOL and HHS in support of the proposed rule on Requirements Related to the Mental Health Parity and Addiction Equity Act (MHPAEA), and offering comments to strengthen the rule.
Displaying results 21-30 (of 325)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >